Chiasma Inc (CHMA.OQ)
CHMA.OQ on NASDAQ Stock Exchange Global Select Market
6.26USD
9:00pm BST
6.26USD
9:00pm BST
Change (% chg)
$0.39 (+6.64%)
$0.39 (+6.64%)
Prev Close
$5.87
$5.87
Open
$5.87
$5.87
Day's High
$6.26
$6.26
Day's Low
$5.75
$5.75
Volume
56,021
56,021
Avg. Vol
78,408
78,408
52-wk High
$8.27
$8.27
52-wk Low
$1.20
$1.20
About
Chiasma, Inc. is a biopharmaceutical company. The Company is engaged in developing and commercializing oral forms of therapies that are available only by injection. Using its Transient Permeability Enhancer (TPE) technology platform, the Company is developing oral therapies. The Company has completed a Phase III clinical trial... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | $70.64 |
| Shares Outstanding(Mil.): | 24.36 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CHMA.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 29.88 | 32.67 |
| EPS (TTM): | -1.28 | -- | -- |
| ROI: | -34.47 | 14.90 | 14.49 |
| ROE: | -35.41 | 16.02 | 15.79 |
Estimates